chr7-39572687-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020192.5(YAE1):āc.662A>Gā(p.Gln221Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000508 in 1,574,470 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_020192.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
YAE1 | NM_020192.5 | c.662A>G | p.Gln221Arg | missense_variant | 3/3 | ENST00000223273.7 | NP_064577.1 | |
YAE1 | NM_001282446.2 | c.251+2060A>G | intron_variant | NP_001269375.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
YAE1 | ENST00000223273.7 | c.662A>G | p.Gln221Arg | missense_variant | 3/3 | 1 | NM_020192.5 | ENSP00000223273.2 | ||
YAE1 | ENST00000432096.2 | c.251+2060A>G | intron_variant | 2 | ENSP00000395777.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152254Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000929 AC: 2AN: 215276Hom.: 0 AF XY: 0.00000857 AC XY: 1AN XY: 116744
GnomAD4 exome AF: 0.0000548 AC: 78AN: 1422216Hom.: 0 Cov.: 31 AF XY: 0.0000581 AC XY: 41AN XY: 705476
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74388
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2024 | The c.662A>G (p.Q221R) alteration is located in exon 3 (coding exon 3) of the YAE1D1 gene. This alteration results from a A to G substitution at nucleotide position 662, causing the glutamine (Q) at amino acid position 221 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at